NCT06423820View on ClinicalTrials.gov

Preoperative Ondansetron Lozenge for Prevention of Postoperative Nausea and Vomiting in Pediatrics Undergoing Squint Surgeries

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

May 21, 2024

Primary Completion Date

January 23, 2025

Study Completion Date

January 23, 2025

Conditions
Ondansetron LozengePostoperative Nausea and VomitingPediatricsSquint
Interventions
DRUG

Ondansetron lozenge

Pediatric patients will receive ondansetron lozenge 4 mg (Ondalenz ©), 2 hours before surgery.

Trial Locations (1)

31527

Tanta University, Tanta

All Listed Sponsors
lead

Tanta University

OTHER

NCT06423820 - Preoperative Ondansetron Lozenge for Prevention of Postoperative Nausea and Vomiting in Pediatrics Undergoing Squint Surgeries | Biotech Hunter | Biotech Hunter